The once-weekly basal insulin, insulin icodec, is currently being developed. ONWARDS 2 focused on comparing the therapeutic effects and tolerability of weekly icodec with daily insulin degludec (degludec) in basal insulin-treated patients with type 2 diabetes.Employing a treat-to-target strategy, a...
Blood type compatibility for transfusions follows a simple rule; you cannot introduce a new blood antigen into someone's body during a transfusion. The transfused blood must either have the same antigens as the recipient's blood or it must contain fewer antigens. The two blood groups of conc...
When we are interested in testing whether a new treatment is more effective in a clinical trial, one possible and simple assumption could be that the survival time in treatment group is proportional to the survival time in control group. Such model assumption is one of the widely used statistic...
obesity, high blood pressure, high blood triglycerides, insulin resistance, and low levels of HDL “good” cholesterol — those who lost nearly 2 percent of their body weight from diet and lifestyle changes in the first month of the study added an 800 mg curcumin supplement to their daily ...